Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non-seroconverted patients during lamivudine therapy. [electronic resource]
Producer: 20080131Description: 1349-55 p. digitalISSN:- 1478-3223
- Adult
- Alanine Transaminase -- blood
- DNA, Viral -- blood
- Drug Resistance, Viral -- drug effects
- Female
- Follow-Up Studies
- Hepatitis B Antibodies -- blood
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- therapeutic use
- Male
- Middle Aged
- Mutation
- Predictive Value of Tests
- Reverse Transcriptase Inhibitors -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.